Evidence map›Paper›PMID 12853418›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2003

Hippocampal cGMP-dependent protein kinase I supports an age- and protein synthesis-dependent component of long-term potentiation but is not essential for spatial reference and contextual memory.

Thomas Kleppisch, Wiebke Wolfsgruber, Susanne Feil, Rüdiger Allmann, Carsten T Wotjak, Sandra Goebbels, Klaus-Armin Nave, Franz Hofmann, Robert Feil

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
5.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 92 citations in OpenAlex.

  1. Trial
  2. Trial
  3. GAP43 Located on Corticostriatal Terminals Restrains Novelty-Induced Hyperactivity in Mice.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  4. The CBEMBO molecular medicine · 2024
    Article
  5. Article
  6. Memory Enhancers for Alzheimer's Dementia: Focus on cGMP.Pharmaceuticals (Basel, Switzerland) · 2021
    Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Real-Time Imaging Reveals Augmentation of Glutamate-Induced CaInternational journal of molecular sciences · 2018
    Article
  12. Article
  13. The DrosophilaCognitive development · 2017
    Article
  14. Article
  15. Article
  16. Article
  17. Cannabinoid CB1 receptor calibrates excitatory synaptic balance in the mouse hippocampus.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2015
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Thomas KleppischInstitut für Pharmakologie und Toxikologie, 80802 München, Germany, Max-Planck-Institut für Psychiatrie, 80804 München, Germany. kleppisch@ipt.med.tu-muenchen.de
Wiebke Wolfsgruber
Susanne Feil
Rüdiger Allmann
Carsten T Wotjak
Sandra Goebbels
Klaus-Armin Nave
Franz Hofmann
Robert Feil
Max Planck Institute of Experimental Medicine · DEMax Planck Institute of Psychiatry · DEMax Planck Society · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

cGMP-dependent protein kinase I (cGKI) is expressed in the hippocampus, but its role in hippocampal long-term potentiation (LTP) is controversial. In addition, whether cGKI is involved in spatial learning has not been investigated. To address these issues, we generated mice with a hippocampus-specific deletion of cGKI (cGKIhko mice). Unlike conventional cGKI knock-out mice, cGKIhko mice lack gastrointestinal and cardiovascular phenotypes and have a normal life expectancy, which enables us to analyze hippocampal synaptic plasticity and learning in young and adult animals. Hippocampal LTP after repetitive episodes of theta burst stimulation was impaired in adult (12-14 weeks of age) but not in juvenile (3-4 weeks of age) cGKIhko mice. The difference in LTP between adult control and cGKIhko mice was abolished by the protein synthesis inhibitor anisomycin, suggesting that the impairment of LTP in adult cGKIhko mice reflects a defect in late-phase LTP. Despite their deficit in LTP, adult cGKIhko mutants showed normal performance in a discriminatory water maze and had intact contextual fear conditioning. These results suggest that hippocampal cGKI supports an age- and protein synthesis-dependent form of hippocampal LTP, whereas it is dispensable for hippocampus-dependent spatial reference and contextual memory.

Indexed as

Age FactorsAnimalsConditioning, PsychologicalCyclic GMP-Dependent Protein KinasesCyclic GMP-Dependent Protein Kinase Type IElectric StimulationExcitatory Postsynaptic PotentialsFemaleHippocampusIntegrasesLearningLong-Term PotentiationMaleMaze LearningMemoryMiceCre recombinaseCyclic GMP-Dependent Protein KinasesCyclic GMP-Dependent Protein Kinase Type IIntegrasesPrkg1 protein, mouseProtein Synthesis InhibitorsViral Proteins

Identifiers

PMID12853418
PMCPMC6740356
OpenAlexW1917963754

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.